Open Access

[Retracted] SET and MYND domain‑containing protein 3 is overexpressed in human glioma and contributes to tumorigenicity

  • Authors:
    • Bin Dai
    • Weiqing Wan
    • Peng Zhang
    • Yisong Zhang
    • Changcun Pan
    • Guolu Meng
    • Xinru Xiao
    • Zhen Wu
    • Wang Jia
    • Junting Zhang
    • Liwei Zhang
  • View Affiliations

  • Published online on: October 15, 2024     https://doi.org/10.3892/or.2024.8825
  • Article Number: 166
  • Copyright : © Dai et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

December-2024
Volume 52 Issue 6

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Dai B, Wan W, Zhang P, Zhang Y, Pan C, Meng G, Xiao X, Wu Z, Jia W, Zhang J, Zhang J, et al: [Retracted] SET and MYND domain‑containing protein 3 is overexpressed in human glioma and contributes to tumorigenicity. Oncol Rep 52: 166, 2024.
APA
Dai, B., Wan, W., Zhang, P., Zhang, Y., Pan, C., Meng, G. ... Zhang, L. (2024). [Retracted] SET and MYND domain‑containing protein 3 is overexpressed in human glioma and contributes to tumorigenicity. Oncology Reports, 52, 166. https://doi.org/10.3892/or.2024.8825
MLA
Dai, B., Wan, W., Zhang, P., Zhang, Y., Pan, C., Meng, G., Xiao, X., Wu, Z., Jia, W., Zhang, J., Zhang, L."[Retracted] SET and MYND domain‑containing protein 3 is overexpressed in human glioma and contributes to tumorigenicity". Oncology Reports 52.6 (2024): 166.
Chicago
Dai, B., Wan, W., Zhang, P., Zhang, Y., Pan, C., Meng, G., Xiao, X., Wu, Z., Jia, W., Zhang, J., Zhang, L."[Retracted] SET and MYND domain‑containing protein 3 is overexpressed in human glioma and contributes to tumorigenicity". Oncology Reports 52, no. 6 (2024): 166. https://doi.org/10.3892/or.2024.8825